Deltec Asset Management LLC Makes New Investment in LENSAR, Inc. $LNSR

Key Points

• Deltec Asset Management LLC acquired a new position in LENSAR, Inc., purchasing 32,500 shares valued at approximately $428,000, representing about 0.28% of the company by the end of the reporting period.
• LENSAR reported a quarterly loss with EPS of -$0.15, missing analysts' estimates and achieving revenue of $11.36 million, significantly lower than the expected $16.55 million.
• The company's stock has a market cap of $147.46 million, with a 52-week range between $4.20 and $17.31, and currently trades at about $12.35.

Deltec Asset Management LLC acquired a new position in shares of LENSAR, Inc. (NASDAQ:LNSR - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 32,500 shares of the company's stock, valued at approximately $428,000. Deltec Asset Management LLC owned approximately 0.28% of LENSAR at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Gabelli Funds LLC acquired a new position in LENSAR during the first quarter worth $191,000. PenderFund Capital Management Ltd. acquired a new stake in shares of LENSAR during the first quarter worth about $236,000. Nuveen LLC acquired a new stake in LENSAR in the 1st quarter valued at approximately $252,000. Acadian Asset Management LLC acquired a new position in shares of LENSAR during the 1st quarter worth approximately $257,000. Finally, Cubist Systematic Strategies LLC bought a new position in shares of LENSAR during the 1st quarter worth approximately $369,000. 40.15% of the stock is currently owned by institutional investors and hedge funds.

LENSAR Stock Performance

NASDAQ:LNSR opened at $12.35 on Wednesday. The stock has a fifty day moving average price of $12.57 and a 200-day moving average price of $13.23. The company has a market cap of $147.46 million, a price-to-earnings ratio of -2.93 and a beta of 0.49. LENSAR, Inc. has a fifty-two week low of $4.20 and a fifty-two week high of $17.31.

LENSAR (NASDAQ:LNSR - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of ($0.08) by ($0.07). LENSAR had a negative return on equity of 737.30% and a negative net margin of 84.49%.The business had revenue of $11.36 million for the quarter, compared to analyst estimates of $16.55 million.

LENSAR Company Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.